Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-311274
Filing Date
2021-10-28
Accepted
2021-10-28 16:03:37
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d195450ddefa14a.htm DEFA14A 40385
2 GRAPHIC g195450g11v20.jpg GRAPHIC 41912
3 GRAPHIC g195450g45k96.jpg GRAPHIC 135847
4 GRAPHIC g195450g56i07.jpg GRAPHIC 30763
5 GRAPHIC g195450g65y27.jpg GRAPHIC 2286
6 GRAPHIC g195450g93p03.jpg GRAPHIC 31658
7 GRAPHIC g195450gra004.jpg GRAPHIC 908
  Complete submission text file 0001193125-21-311274.txt   377540
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-50484 | Film No.: 211358196
SIC: 2834 Pharmaceutical Preparations